It has been recently demonstrated that lysophosphatidylcholine (lysoPC), which accumulates in oxidatively modified low density lipoprotein (Ox-LDL), produces a selective unresponsiveness to receptor-regulated endothelium-dependent arterial relaxation (EDR) that mimics the condition observed in the early-onset atherosclerotic arteries.1-4 LysoPC in Ox-LDL impairs the EDR that is mediated by stimulations of endothelial surface receptors, whereas lysoPC generally has no effect on EDR induced by calcium ionophores that bypass receptor-dependent membrane regulation. 1, 2 Protein kinase C (PKC) mediates intracellular signal transduction in a variety of cellular functions that include cell proliferation, morphological transformation, modulation of gene expression, and many other functions.5-7 PKC is also known to exert inhibitory actions on agonist-induced inositol 1,4,5-trisphosRhate (IP3) formation and subsequent intracellular calcium mobilization. 5, [8] [9] [10] The inhibitory actions of activated PKC on receptor agonist-mediated early signal transduction have been shown in many different types of cells, including endothelial cells.10 Furthermore, a variety of lipids, including lysophospholipids, are capable of activating PKC.1' Therefore, the present study ad-tion12 and grown to confluence on gelatin-coated dishes in medium 199 with 15% fetal calf serum (FCS), endothelial growth factor, and antibiotics. After confluence was reached, the medium was replaced with medium 199 that contained 5% FCS and antibiotics without growth factor for 48 hours before the experiments. Only primary cultures of HUVECs were used for the experiments. Confluent cultures of HUVECs showed the typical cobblestone morphology, and almost all of those cells contained factor VIII-related antigen as determined by the use of indirect immunofluorescence. 12 
Measurement of Inositol 1,4,5-Trisphosphate Production
The monolayers of cultured HUVECs on 60-mm Petri dishes at a density of 1 x 105 cells/cm2 were washed three times with Hanks' balanced salt solution (HBSS) and incubated with serum-free medium 199 that contained 10 mM LiCl for 20 minutes. The cells were then stimulated by thrombin (Th, 2 units/ml) or histamine (His, 0.1 mM) after preincubation with phospholipids for the appropriate times or with phorbol 12-myristate 13-acetate (PMA) for 5 minutes (as indicated in the text and figure legends). In some experiments the cells were pretreated for 5 minutes with PKC inhibitors before the incubation with phospholipids or PMA. In the experiment that examined the effects of lysoPC on the agonistinduced 1P3 production in PKC-downregulated cells, confluent monolayers of cells were incubated for 24 hours with 100 nM PMA in medium 199 that contained 2% FCS. Then the culture medium was replaced with serum-free medium 199 that contained 10 mM LiCl after washing three times with serum-free medium 199; afterwards, the cells were incubated for 20 minutes at 37°C. Cells were then stimulated by Th after preincubation for 1 minute with or without lysoPC.
Stimulation by Th or His was terminated with aspiration of the solution and addition of 2.0 ml ice-cold 15% trichloroacetic acid (TCA) and followed by incubation for 30 minutes on ice. The cells were then removed from the dishes by scraping. After centrifugation of the mixture, the supernatant was extracted with diethylether to remove the TCA. 1P3 levels were determined by the use of a protein binding assay system13 (Amersham Intl., code TRK 1000) after adjustment of the pH to 7.3 by the addition of Tris buffer. In a preliminary experiment that examined the time courses of Th-or Hisinduced 1P3 production, peak increases of 1P3 were obtained within 20 seconds of the addition of Th or His. On the basis of these time course observations, the stimulations were terminated at 20 seconds after the admixture of Th or His.
Measurement of Cytosolic Free Calcium Elevation
The fluorescent calcium indicator fura 1, glucose 10, and HEPES 20) and followed by exposure to 4 ,uM fura 2-AM for 30 minutes at 37°C. The cells were washed three times with HBSS, resuspended in KRH (3x106 cells/ml), and then transferred into a quartz cuvette. The suspension was stirred continuously and maintained at 37°C. Fluorescence signals were monitored on a Hitachi F-3000 fluorescence spectrophotometer (Hitachi, Tokyo) at excitation and emission wavelengths of 340 and 505 nm, respectively. The cells were then stimulated by Th (2 units/ml) or His (0.1 mM) after preincubation with phospholipids for the appropriate times or with PMA for 5 minutes (indicated in the text and figure legends). In some experiments, the cells were pretreated for 5 minutes with PKC inhibitors before the incubation with phospholipids or PMA.
[ After incubation for 8 minutes at 30°C, 15-gul aliquots were spotted on phosphocellulose paper squares, and the radioactivity was counted. 16 The standard reaction mixture that included 5 ,ug/ml diolein and 50 ,ug/ml phosphatidylserine was used when diolein and phosphatidylserine-dependent phosphorylation of the substrate was assessed for the PKC activity in the cytosolic and soluble particulate fractions from the cells pretreated with lysoPC or PMA. The standard reaction mixture that included 50 ,ttg/ml phosphatidylserine and varying concentrations of lysoPC or PMA was used for the examination of the direct effects of lysoPC or PMA on the activity of PKC purified from the cytosolic fraction of the untreated cells by means of a diethylaminoethyl-Sephacel column.17 Protein concentrations were determined by the method of Bradford,18 with bovine serum albumin as the standard.
Materials
All reagents for the cell culture were obtained from GIBCO. Radioactive materials came from Amersham Intl., Tokyo; staurosporine from Kyowa Hakko Co. Ltd., Tokyo; H-7 and HA-1004 from Seikagaku Kogyo Co. Ltd., Tokyo; endothelial growth factor (bovine pituitary) from Collaborative Research, and PKC substrate from Bachem, Torrance, Calif. Other chemicals were obtained from Sigma Chemical Co., St. Louis, Mo. Phospholipids were used after sonication in HBSS.
Staurosporine, fura 2-AM, PMA, or A23187 was dissolved in dimethyl sulfoxide (DMSO). Final concentrations of DMSO were less than 0.1% in the solution.
Indomethacin solution was prepared in an equimolar
(1-mM) concentration of Na2CO3.
Statistical Analysis
All values were expressed as mean+SEM. Statistical evaluation of the data was performed by Student's t test for paired or unpaired observations. When more than 
Protein Kinase C Assay
As shown in Figure 6 , the incubation of HUVEC monolayers in culture dishes with lysoPC (palmitoyl, 1 ,uM) caused a significant increase in diolein and phosphatidylserine-dependent PKC activity in the particulate fraction of the cells, with a maximum (by a 32% increase from the baseline value) at 1 minute after the addition of lysoPC into the culture medium, and the activity subsequently decreased to the baseline value. The PKC activity in the cytosolic fraction slightly decreased during the increase of the particulate PKC activity (a 5-13% decrease from the baseline value). In comparison, the incubation of the cells with PMA (100 nM) also caused an increase in PKC activity in the particulate fraction, with a maximum (a 67% increase from the baseline value) at 5 minutes after the addition of PMA into the medium, and at the same time the PKC activity in the cytosolic fraction decreased by 31% from the baseline value at 5 minutes. The incubation of HUVECs with 100 nM PMA for 24 hours resulted in an 87% loss of the measurable PKC activity in both the cytosolic and particulate fractions assessed by diolein and phosphatidylserine-induced PKC activation, as shown in Table 2 . Discussion According to current concepts,21-23 the binding of an agonist to a cell surface receptor, which is coupled by a G-protein to a specific phospholipase C, leads to the hydrolysis of phosphatidylinositol 4,5 -bisphosphate. PKC also plays crucial roles in the signal transduction that involves cellular proliferation and modulation of gene expression.5-79 Therefore, lysoPC in atherosclerotic arterial walls could activate PKC in a variety of cells in the artery, which may play a role in the mechanisms of their mitogenic changes and functional alterations in atherosclerotic arteries.
In conclusion, lysoPC, which is abundant in atherosclerotic arterial walls, inhibits surface receptor-mediated intracellular signals in human endothelial cells, and PKC activation could be at least partially involved in the negative regulation by lysoPC. These intracellular actions of lysoPC may play a role in the mechanism of lysoPC-induced unresponsiveness to cell surface receptor-regulated EDR, which closely mimics that observed in early-onset atherosclerotic arteries.
